| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/02/2011 | EP2278995A2 Compounds for use in therapy |
| 02/02/2011 | EP2278994A2 Flagellin polypeptide vaccines |
| 02/02/2011 | EP2278990A2 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for treating or detecting streptococcal diseases |
| 02/02/2011 | EP2278987A2 Modulation and repletion/enhancement of the complement system for treatment of trauma |
| 02/02/2011 | EP1951303B1 Therapy with anti-cd4 antibodies and radiation |
| 02/02/2011 | EP1875247B1 Selective modulation of tumour necrosis factor receptors in therapy |
| 02/02/2011 | EP1805222B1 Antibodies directed to the mammalian eag1 ion channel protein |
| 02/02/2011 | EP1618126B1 Sars-related proteins |
| 02/02/2011 | EP1603949B9 Antibodies against human il-21 receptor and uses therefor |
| 02/02/2011 | EP1556083B1 Methods for treating post-surgical pain by admisnistering an antibody against nerve growth factor and compositions containing the same |
| 02/02/2011 | CN1970573B Neutrality monoclonal antibody 3E1 for resisting ricin, its preparation method and uses |
| 02/02/2011 | CN1882358B Vaccine composition admixed with an alkylphosphatidylcholine |
| 02/02/2011 | CN1764474B Immunogenic composition and methods |
| 02/02/2011 | CN101965403A Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |
| 02/02/2011 | CN101965366A Immunoconjugates targeting cd138 and uses thereof |
| 02/02/2011 | CN101965365A Antibody capable of combining the soluble ass oligomer specifically and application thereof |
| 02/02/2011 | CN101965195A Compositions and methods for drug delivery |
| 02/02/2011 | CN101965183A Ophthalmic nsaids as adjuvants |
| 02/02/2011 | CN101962648A Duck source coronavirus ORF1a protein gene and cloning method and application thereof |
| 02/02/2011 | CN101962625A Salmonella choleraesuis gene deletion mutant without resistant marker and vaccine thereof |
| 02/02/2011 | CN101962405A Humanized breast cancer antigen and antibody thereof |
| 02/02/2011 | CN101962400A Linear epitope minimum motif peptide of human papilloma virus type 58 L1 protein and application thereof |
| 02/02/2011 | CN101961496A Cancerous disease modifying antibodies |
| 02/02/2011 | CN101961488A Method for preparing serum for resisting Muscovy duck parvovrius |
| 02/02/2011 | CN101961487A Echinococcosis granulosa gene engineering vaccine candidate P-29 |
| 02/01/2011 | US7881871 Method for designing surfaces |
| 02/01/2011 | US7879990 Polynucleotides encoding antibodies that bind to the C35 polypeptide |
| 02/01/2011 | US7879983 Binding member which binds to both Lewis-y and Lewis-b haptens, and its use for treating cancer |
| 02/01/2011 | US7879981 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 02/01/2011 | US7879980 Monoclonal antibodies to human CTLA-8 (IL-17A) |
| 02/01/2011 | US7879977 Methods and reagents for decreasing clinical reaction to allergy |
| 02/01/2011 | US7879976 Method for stabilizing a protein |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
| 02/01/2011 | US7879801 For therapy of cancer and viral infections |
| 02/01/2011 | US7879791 Regulation of T cell-mediated immunity by tryptophan |
| 02/01/2011 | US7879609 Regulatory segments of the human gene for telomerase reverse transcriptase |
| 02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 02/01/2011 | US7879570 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 02/01/2011 | US7879342 Vaccine adjuvant and making and using the same |
| 02/01/2011 | US7879341 from Clostridium botulinum, neurotoxin being free of complexing proteins naturally present; improved stability via hyaluronic acid, polyvinylpyrrolidone and polyethyleneglycol; cryoprotectants; cosmetic conditions, blepharospasm, hemifacial spasms, spasmodic torticollis, spasticities, migraine, back pain |
| 02/01/2011 | US7879340 blocking, reducing allergic rhinitis via antibodies contacting antigen, by administration of neurotoxin derived from Clostridium; absorbent pledgets, biodegradable carriers; lyophilization; liposomes |
| 02/01/2011 | US7879339 herpes simplex virus (HSV-2); positively charged liposome containing an expressible polynucleotide coding for an immunogenic peptide; polynucleotide operatively coding for a physiologically active form of either gD, VP11/12, VP13/14, VP22 or a combination thereof |
| 02/01/2011 | US7879338 Expression vector comprising nucleotide sequences coding norwalk virus capsid protein for use in generating vaccine for prevention and treatment of gastrointestinal disorders |
| 02/01/2011 | US7879337 Mutant porcine reproductive and respiratory syndrome virus |
| 02/01/2011 | US7879336 Vaccines and methods to treat canine influenza |
| 02/01/2011 | US7879335 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879333 Methods for preparing and delivering adjuvant compositions |
| 02/01/2011 | US7879332 Ultra-high yield intravenous immune globulin preparation |
| 02/01/2011 | US7879331 Using salt extraction and diafiltration to isolate gamma globulin from plasma |
| 02/01/2011 | US7879329 Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 02/01/2011 | US7879328 Antibodies that immunospecifically bind to B lymphocyte stimulator |
| 02/01/2011 | US7879327 Treating breast cancer via administration of trastuzumab and amrubicinol |
| 02/01/2011 | US7879326 Human neutralizing monoclonal antibodies to H5N1 influenza A virus |
| 02/01/2011 | US7879325 HER2 antibody composition |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | US7879322 Compositions and methods for use for antibodies against sclerostin |
| 02/01/2011 | US7879111 System and method for RFID transfer of MAC, keys |
| 02/01/2011 | US7878978 Use of relaxin to increase arterial compliance |
| 02/01/2011 | CA2551193C Live genetically attenuated malaria vaccine |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2393298C Compositions and methods for stabilizing biological molecules upon lyophilization |
| 02/01/2011 | CA2380550C C type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/01/2011 | CA2354508C Streptococcal c5a peptidase vaccine |
| 02/01/2011 | CA2282779C Formulation comprising an antigen, an adjuvant and an amino acid for use in immunization. |
| 02/01/2011 | CA2273194C Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 02/01/2011 | CA2188432C Melanoma antigens |
| 02/01/2011 | CA2125472C A method for generation of antibodies to cell surface molecules |
| 02/01/2011 | CA1341610C Osteogenic polypeptides |
| 01/27/2011 | WO2011011797A2 Cytokine compositions and methods of use thereof |
| 01/27/2011 | WO2011011775A1 Methods and compositions for treating and preventing disease associated with avb5 integrin |
| 01/27/2011 | WO2011011688A2 DENDRITIC CELL VACCINES FOR ASPARAGINYL- β - HYDROXYLASE EXPRESSING TUMORS |
| 01/27/2011 | WO2011011617A1 Therapeutic compositions and methods |
| 01/27/2011 | WO2011011495A1 Recombinant ectodomain expression of herpes simplex virus glycoproteins in yeast |
| 01/27/2011 | WO2011011474A1 Methods of treating her2 positive cancer with her2 receptor antagonist in combination with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 01/27/2011 | WO2011011453A2 Phenotyping tumor-infiltrating leukocytes |
| 01/27/2011 | WO2011011416A1 Compositions for use in identification of arenaviruses |
| 01/27/2011 | WO2011011384A2 Synthesis of dendrimer conjugates |
| 01/27/2011 | WO2011011027A1 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases |
| 01/27/2011 | WO2011009864A1 Novel influenza virus |
| 01/27/2011 | WO2011009854A2 Vaccine for the prevention of acute lymphoblastic leukemia |
| 01/27/2011 | WO2011009771A2 Immunogenic and therapeutic compositions for streptococcus suis |
| 01/27/2011 | WO2011009613A1 Enzymatic composition for the digestion of chicken embryos |
| 01/27/2011 | WO2011009173A1 Cancer immunotherapy |
| 01/27/2011 | WO2011009152A1 Vaccine |
| 01/27/2011 | WO2010141312A3 Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
| 01/27/2011 | WO2010125565A3 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder |
| 01/27/2011 | WO2010096434A3 Specific binding proteins and uses thereof |
| 01/27/2011 | WO2009135855A3 Encapsulation of biologically active agents |
| 01/27/2011 | US20110023135 Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions |
| 01/27/2011 | US20110021974 Retinitis pigmentosa treatment and prophalaxis |
| 01/27/2011 | US20110021970 Non-invasive energy upconversion methods and systems for in-situ photobiomodulation |
| 01/27/2011 | US20110021747 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/27/2011 | US20110021416 Compositions, methods and uses for treating bacterial infections |
| 01/27/2011 | US20110021413 Methods of suppressing microglial activation |
| 01/27/2011 | US20110020951 Purified sr-p70 protein |
| 01/27/2011 | US20110020928 Immunovectors which can be used for the intracellular and intranuclear transport |
| 01/27/2011 | US20110020908 Monoparamunity inducers based on attenuated rabbit myxoma viruses |